Comparison between Clinical Utility of CXCL-8 and Clinical Practice Tumor Markers for Colorectal Cancer Diagnosis

Table 3

Performance of CXCL-8, CEA, and CA19-9 for predicting the colorectal cancer occurrence risk.

Variables	No. subjects	Cut-off value	Multivariate analysis
			OR	95% CI	value
CEA (ng/mL)	298	<5	1 (R)	—
	79	≥5	13.83		0.001
CA19-9 (U/mL)	340	<37	1 (R)	—
	37	≥37	7.96		0.053
CXCL-8 (pg/mL)	135	<24.92	1 (R)	—
	242	≥24.92	7.76		<0.001